BriaCell Therapeutics Corp. (BCTX) Daily Stock Prediction

BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing approaches for the management of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.

Sector:

Healthcare

Industry:

Biotechnology

Address:

BriaCell Therapeutics Corp. Bellevue Centre 235 West 15th Street Suite 300 West Vancouver BC V7T 2X1 Canada

Website:

Home

Phone:

604-921-1810